Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance andIn VivoDrug Release in Rabbit Eyes
about
Lipid Nanoparticles for Ocular Gene DeliverySolid lipid nanoparticles for ocular drug delivery.Development and validation of UHPLC method for the determination of cyclosporine A in biological samples.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment.Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research.[Nanoparticles as drug delivery systems in ophthalmology].Chitosan nanoparticles: a contribution to nanomedicineCationic Gelatin Nanoparticles for Drug Delivery to the Ocular Surface:In VitroandIn VivoEvaluation
P2860
Q26823895-D4E78215-8461-4F46-84C6-2B4ABB66EAC9Q34116807-FD451513-EB26-4842-A3DC-2ED083CAC2DAQ35174120-4E6834F6-4B70-48C6-AE16-CEFD8A6E1D13Q38227621-52A9FFA8-126F-49D6-A232-2C08CB21E33DQ38558905-0F73AF19-17BA-4497-BB0E-08E5263F2042Q38573732-42EA51E1-7241-4B38-A4B3-680985707DA6Q38648168-1AD79C2E-02EE-47C6-B2D6-B2F46613B8B5Q38987118-2285287B-E92E-4F92-8414-197CC789656AQ41573602-D099922E-E203-41B4-8DFE-409CEBFBFFEAQ41612480-32BF434F-C1FA-459E-8992-5C0C6802DA49Q43811991-775B1EFB-BC98-463D-A1D4-755A8A9E6EF0Q47447720-E1032A54-C54F-45D9-9F1E-C08ECCA549AAQ47771876-D9C014A3-5085-4D59-9C33-7A899C5E83CBQ50129671-8BDAFFE2-B106-40B5-A96A-58A65C5D266AQ57342948-303B9559-A86C-4EB2-81B1-3AB0265BC940Q59016771-F37C9D4C-A89D-4836-811D-05497B2805E3
P2860
Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance andIn VivoDrug Release in Rabbit Eyes
description
im November 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 2009
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2009
@uk
name
Cyclosporine A-Loaded Solid Li ...... ivoDrug Release in Rabbit Eyes
@en
Cyclosporine A-Loaded Solid Li ...... ivoDrug Release in Rabbit Eyes
@nl
type
label
Cyclosporine A-Loaded Solid Li ...... ivoDrug Release in Rabbit Eyes
@en
Cyclosporine A-Loaded Solid Li ...... ivoDrug Release in Rabbit Eyes
@nl
prefLabel
Cyclosporine A-Loaded Solid Li ...... ivoDrug Release in Rabbit Eyes
@en
Cyclosporine A-Loaded Solid Li ...... ivoDrug Release in Rabbit Eyes
@nl
P2093
P2860
P50
P1433
P1476
Cyclosporine a-loaded solid li ...... vo drug release in rabbit eyes
@en
P2093
Carla Caramella
Evren H Gökçe
Tamer Güneri
P2860
P304
P356
10.3109/02713680903261405
P577
2009-11-01T00:00:00Z